In 2024, Luxembourg leads in international collaboration for biotechnology publications, with 76.44% of its scientific work involving partners from other countries. Iceland and Saudi Arabia follow closely with 75.27% and 69.17%, respectively. Countries such as Denmark, Belgium, Sweden, and Singapore exhibit mid-tier collaboration levels, ranging from 55.54% to 53.34%. Meanwhile, countries like the United States, China, and India display lower international collaboration, with figures at 28.11%, 16.56%, and 13.62%, respectively. Other notable observations include significant collaboration seen in smaller nations such as Peru at 68.55% and Costa Rica at 52.92%.
Future trends to watch for include potential shifts due to evolving global partnerships and funding opportunities. Countries currently exhibiting high collaboration rates might influence others to develop similar strategies. Additionally, emerging markets and advancements in digital communication technologies could enable greater international cooperation in the biotechnology sector.
Top countries in Share of Scientific Publications Involving International Collaboration in Biotechnology by Country
| # | 10 Countries | Percent | Last Year | |
|---|---|---|---|---|
| 1 | 1 Luxembourg | 76.44 | 2023 | View data |
| 2 | 2 Iceland | 75.27 | 2023 | View data |
| 3 | 3 Saudi Arabia | 69.17 | 2023 | View data |
| 4 | 4 Peru | 68.55 | 2023 | View data |
| 5 | 5 Denmark | 55.54 | 2023 | View data |
| 6 | 6 Belgium | 54.14 | 2023 | View data |
| 7 | 7 Sweden | 53.53 | 2023 | View data |
| 8 | 8 Singapore | 53.34 | 2023 | View data |
| 9 | 9 Costa Rica | 52.92 | 2023 | View data |
| 10 | 10 Switzerland | 52.88 | 2023 | View data |
